Serum ADAMTS-13 Levels as an Indicator of Portal Vein Thrombosis

Table 1

Baseline characteristics of the analyzed groups.

	Patients with PVT; Group 1 (); (Mean ± SD)	Patients without PVT; Group 2 (); (Mean ± SD)	Healthy controls; Group 3 (); (Mean ± SD)
Age (years)	57.7 ± 12.9	52.6 ± 12.6	39.7 ± 8.9
ADAMTS-13 (ng/mL)	695 ± 144	1069 ± 110	1301 ± 203
PLT × 10^3/μL	116 ± 69	110 ± 63	239 ± 79
INR	1.38 ± 0.29	1.36 ± 0.29	1.04 ± 0.08